ReviewExperimental hematology & oncology2017

Interferon-alpha-based immunotherapies in the treatment of B cell-derived hematologic neoplasms in today's treat-to-target era.

Li Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.